Methimazole (l-methyl-2-mercaptoimidazole) inhibits both the mono-and the o-dihydroxy-phenolase activities ofmushroom tyrosinasewhen assayed spectrophotometrically. With DL-3,4-dihydroxyphenylalanine as substrate, the inhibition was found to be a mixed-type one with KI 4.6 x 10-6 x. We found that methimazole can interact with the oxidation products of o-dihydroxyphenols, probably with o-quinones, to form a conjugate. The conjugate formed between methimazole and o-benzoquinone was separated by chromatography on Sephadex G-10 and was characterized by an absorption maximum at 248-260 nm. Our data suggest that methimazole inhibits mushroom tyrosinase activity in two ways: (i) by conjugating with o-quinones, thereby causing an apparent inhibition in pigmented product formation as judged by the spectrophotometric assay; and (ii) by chelating copper at the active site of the enzyme, as judged by assaying the release of 3HHO from L-[3,5-3H]tyrosine.
INTRODUCTION
Tyrosinase catalyses two reactions in which molecular oxygen is the hydrogen acceptor and phenols are the hydrogen donors: monohydroxyphenol + 02 +AH2 -o-dihydroxyphenol+H20+A (1) o-dihydroxyphenol +ja02-* o-quinone+ H20 (2) where AH2 represents a hydrogen donor (reductant) (Mason, 1965) . Reactions 1 and 2 are referred to as the monohydroxyphenolase and o-dihydroxyphenolase activities of tyrosinase, respectively.
Tyrosinases isolated from different sources were shown to be inhibited by thiol compounds such as diethyldithiocarbamate (Anderson, 1968) , 2-mercaptobenzothiazole (Palmer & Roberts, 1967) , cysteine (Pierpoint, 1966) and GSH (Seiji et al., 1969) .
Methimazole is a thiourea derivative which contains a thiol group; it was reported to be an inhibitor of mushroom tyrosinase (Hanlon & Shuman, 1975) and of dopamine fl-hydroxylase (Stolk & Hanlon, 1973) , both being copper-containing enzymes. The inhibition of mushroom tyrosinase and ofdopamine fl-hydroxylase by methimazole was attributed to the Cu2+-chelating ability of methimazole (Hanlon & Shuman, 1975; Stolk & Hanlon, 1973) .
According to Anderson (1968) , some thiol compounds act as inhibitors of tyrosinase because of their ability to reduce o-quinones back to the parent o-dihydroxyphenols (e.g. thioglycollate and mercaptobenzothiazole) (Palmer & Roberts, 1967; Pierpoint, 1966) and cysteine at certain concentrations (Pierpoint, 1966) , while other thiol compounds act as inhibitors because of their ability to form a stable conjugate with the o-quinones formed (GSH, cysteine and methionine) (Cowley & Palmer, 1979; Gupta & Vithayathil, 1982; Pierpoint, 1966; Roston, 1960; Sanada et al., 1972; Seiji et al., 1969) .
Since methimazole is a thiol compound, we thought it was important to find out if it inhibits tyrosinase activity solely due to its ability to chelate Cu2+ (as reported by Hanlon & Shuman, 1975) , or also due to its potential ability to reduce and/or to conjugate with the o-quinone formed in the course of the reaction.
EXPERIMENTAL

Monohydroxyphenolase activity
Monohydroxyphenolase activity ofmushroom tyrosinase was assayed either spectrophotometrically, or by a radioassay.
Spectrophotometric assay. The reaction mixture included, in a total volume of 3.0 ml: 3 mM-L-tyrosine, 47 mm-sodium phosphate (pH 6.5) and 25 jug of mushroom tyrosinase (added last). The rate of formation of dopachrome as a function of time was followed at 475 nm. The lag period of tyrosine hydroxylation was estimated by extrapolation ofeach curve to the x-axis, as suggested by Pomerantz & Warner (1967) .
Radioassay. The hydroxylation oftyrosine to dopa was measured by determining the amount of 3HHO released from L-[3,5-3H]tyrosine, essentially as described by Pomerantz (1964) .
o-Dihydroxyphenolase activity
The o-dihydroxyphenolase activity of mushroom tyrosinase was assayed as described by Andrawis & Kahn (1985) .
All the spectrophotometric measurements were conducted using a Varian 635 spectrophotometer equipped with a recorder.
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Abbreviations used: mushroom tyrosinase, monophenol mono-oxygenase (monophenol, dihydroxyphenylalanine:oxygen oxidoreductase, EC 1.14.18.1), also known as phenolase, catecholase, polyphenoloxidase (PPO) and cresolase; methimazole, 1-methyl-2-mercaptimidazole (1-methyl-2-thiolimidazole); dopa, 3,4-dihydroxyphenylalanine; dopamine, 3,4-dihydroxyphenethylamine.
Chemical preparation of a solution of 4-methyl-o-benzoquinone A 10 mm solution of 4-methylcatechol in 100 ml of anhydrous diethyl ether was oxidized with 0.65 g ofAg2O (Cason, 1948) , filtered, and the filtrate obtained was used as a stock of4-methyl-o-benzoquinine. Aliquots of0.1 ml of this filtrate were used as needed. Non-enzymic synthesis of the catechol-methimazole conjugate and its separation by chromatography on Sephadex G-10
The conjugate of o-quinone of catechol (o-benzoquinone) with methimazole was prepared chemically by the method of Sanada et al. (1972) . Catechol (440 mg) was oxidized by 4 g of Ag2O in 200 ml of anhydrous diethyl ether, filtered and the ether layer was mixed by shaking with 100 ml of aqueous solution containing 1100 mg ofmethimazole. After incubation for 15 min, the aqueous layer was washed twice with 200 ml of diethyl ether to remove unreacted catechol. The aqueous layer was concentrated to 10 ml using the Speed Vac Concentrator (Savant, model RT lOOA). The sample was then centrifuged at 27000 g for 15 min and the supernatant was saved for column chromatography.
A sample of the supernatant was applied to a column of Sephadex G-10 (2.5 cm x 60 cm) and the column was eluted with distilled water. Fractions (1.5 ml) were collected in an ISCO model 328 fraction collector attached to a UA-5 monitor, and the A280 was recorded. 
Materials
Mushroom tyrosinase (grade III), DL-dopa, L-tyrosine, methimazole, dopamine, catechol and DL-Cysteine hydrochloride were obtained from Sigma, 4-methylcatechol was obtained from Fluka, and L-[3,5-3H]tyrosine was obtained from The Radiochemical Centre (Amersham, Bucks., U.K.). All other chemicals and biochemicals were reagent grade.
RESULTS AND DISCUSSION
Effect of methimazole on the monohydroxyphenolase activity of mushroom tyrosinase
The monohydroxyphenolase activity of mushroom tyrosinase (reaction 1 above), in the absence of an exogenous reductant, is characterized by an initial lag period.
Using tyrosine as the substrate, the data in Fig. 1 show the kinetics of tyrosine hydroxylation (dopachrome formation at 475 nm) in the presence and absence (control) of different concentrations of methimazole. The data in Fig. 1 show that methimazole extends the lag period oftyrosine hydroxylation by mushroom tyrosinase and also inhibits the rate of dopachrome formation following the lag period. Effect of methimazole on the o-dihydroxyphenolase activity of mushroom tyrosinase
The data in Fig. 2 show that methimazole inhibits the o-dihydroxyphenolase activity of mushroom tyrosinase in the presence of each of the substrates tested. It can be seen that inhibition of the o-dihydroxyphenolase activity of mushroom tyrosinase by methimazole was more effective when DL-dopa or dopamine, rather than catechol or 4-methylcatechol, was used as the substrate.
Kinetic data obtained by using different concentrations of DL-dopa and different concentrations of methimazole were subjected to analysis by double-reciprocal plots of velocity versus methimazole concentration. The results shown in Fig. 3 indicate a mixed-type inhibition with Ki 4.6 x 10-6 M and Km 0.64 x 10-3 M. These data confirm those obtained by Hanlon & Shuman (1975) , who also found that methimazole inhibited mushroom tyrosinase in a mixed-type way with Ki 10-6 M.
The inhibition of mushroom tyrosinase activity by methimazole was reversed by exhaustive dialysis against 0.05 M-sodium phosphate buffer (pH 6.5), indicating that methimazole does not inactivate the enzyme but only inhibits it. Does methimazole inhibit mushroom tyrosinase activity due to its ability to reduce o-quinones back to o-dihydroxyphenol?
The possibility that methimazole, being a thiol compound, can reduce o-quinone back to o-dihydroxyphenol was tested using DL-dopa as the substrate. The oxidation of dopa by mushroom tyrosinase in the presence of a compound that can reduce dopaquinone back to dopa, i.e. ascorbate, is characterized by an initial lag period in dopachrome formation (Pomerantz, 1966) .
As soon as the reductant is completely oxidized, the formation of dopaquinone, dopachrome and related pigmented oxidation products of DL-dopa can be detected.
Cysteine, at low concentrations, is known to reduce o-quinones back to o-dihydroxyphenols (Pierpoint, 1966;  The reaction mixture included, in a total volume of 3 ml, 6.6 mm of the indicated o-dihydroxyphenol, 47 mm-sodium phosphate (pH 6.5), methimazole as indicated and 10-20 ,ug of mushroom tyrosinase (added last). (a) Oxidation of 4-methylcatechol (-) and catechol (---) was followed at 410 nm; (b) oxidation of DL-dopa (-) and of dopamine (---) was followed at 475 nm.
[ The reaction mixture included, in a total volume of 3 ml, 47 mm-sodium phosphate buffer (pH 6.5), 50,g of mushroom tyrosinase (added last), different concentrations of methimazole and DL-dopa as indicated. Velocity (v) refers to initial o-dihydroxyphenolase activity (AA475/min). Kahn, 1985 Several instances are known in which thiol compounds form non-enzymically a stable conjugate with o-quinone (Anderson, 1968; Cowley & Palmer, 1979; Pierpoint, 1966 Pierpoint, , 1969 Roston, 1960; Sanada et al., 1972; Seiji et al., 1969) .
We tested the possible formation of a conjugate between methimazole and oxidation products of an o-dihydroxyphenol in a non-enzymic system as follows. o-Quinones can be prepared chemically by oxidizing o-dihydroxyphenols with an oxidant such as Ag2O (Cason, 1948) . The data in Fig. 5 show that 4-methylo-benzoquinone (prepared chemically) is characterized by a peak at around 400 nm and that the spectrum is stable for at least 5 min. When 4-methyl-o-benzoquinone was mixed with methimazole, the spectrum scanned after 1 min had the same shape as that of the o-quinone alone, but of lower absorption, whereas after 5 min of incubation the peak at 400 nm disappeared and a new one in the visible range was not detected.
Since we showed above that methimazole does not reduce o-quinone back to o-dihydroxyphenol (Fig. 4) , the data in Fig. 5 strongly suggest the formation of a conjugate between 4-methyl-o-benzoquinone and methimazole.
Additional experiments were made in an attempt to synthesize and isolate an o-quinone-methimazole conjugate. The conjugate between o-benzoquinone and methimazole was synthesized as described in the Experimental section and its isolation was achieved by chromatography on a column of Sephadex G-10. . Separation of the benzoquinone-methimazole conjugate by chromatography on Sephadex G-10 column A sample of the supernatant obtained when preparing the conjugate ofo-benzoquinone-methimazole (see the Experimental section) was applied to a Sephadex G-10 column (2.5 cm x 60 cm) and the column was eluted with water. Fractions (1.5 ml) were collected in an ISCO model 328 fraction collector attached to a UA-5 monitor and A280 was recorded (as an arbitrary wavelength to aid in locating the position of elution of the various components, rather than to aid in their identification). The reaction mixture included, in a total volume of 3 ml, 0.33 mM-4-methyl-o-benzoquinone (added last) (0.1 ml of filtratepreparedchemicallyasdescribedinthe Experimental section), 6.6 mM-sodium phosphate buffer (pH 6.5), and either no methimazole (---) or 0.33 mM-methimazole ( ). Absorbance of each mixture was recorded after 1 or 5 min (as indicated) after adding the 4-methyl-o-benzoquinone, using water as the blank.
Three regions were resolved during chromatography: I, II and III, with I being eluted at the void volume of the column (V') (105 ml) and II and III being eluted at volumes of 132 ml and 318 ml, respectively (Fig. 6) .
The spectrum of each of the fractions eluted from Sephadex G-10 (Fig. 6 ) was scanned and it was found that they absorb in the u.v. region but not in the visible region of the spectrum. o-Benzoquinone is characterized by a peak in the visible range (388 nm) (Duckworth & Coleman, 1970) . The observation that none of the fractions eluted absorb in the visible range indicates that o-benzoquinone itself was not present.
The u.v. spectra offractions eluted from Sephadex G-10 in region I were characterized by a high peak at 262 nm and a shoulder at 224 am (Fig. 7, 1 ). Since these fractions were eluted at V0, they must be of relatively high Mr, probably representing a polymer of o-benzoquinone.
The u.v. spectra of various fractions eluted from the column in region II were not identical: fractions eluted at volumes of 130-145 ml (II-I) were characterized by a peak at 260 am (Fig. 7, II-I) and those eluted at volumes of 148-161 ml (II-2) were characterized by a peak at 248 am and a shoulder at 310 am (Fig. 7, 11-2 ).
The u.v. spectra of fractions eluted from the column in region III were all the same and were characterized by a high peak at 250 nm and a small one at 210 nm (Fig. 7, III) , identical with the spectrum of untreated methimazole.
The observation that the u.v. spectrum of fractions of region II was different from that of methimazole alone (a peak at 250 nm and 210 nm) and of catechol alone (278 nm and a shoulder at 212 nm) suggests that region II of Fig. 7 contained a new compound, probably the conjugate. A control containing o-benzoquinone alone (prepared chemically) without methimazole was also chromatographed on a column of Sephadex G-10 and eluted with distilled water (results not shown). A major region was eluted at V0 and a very small region was eluted at an elution volume of 280 ml. A region equivalent to region II of Fig. 6 was not detected in chromatography of the control on Sephadex G-10.
The observation that the elution profile of obenzoquinone treated with methimazole (data in Fig. 6 ) was different from that of o-benzoquinone alone (control) strongly suggests that region II eluted from Sephadex G-10 (Fig. 6) represents the catecholmethimazole conjugate.
Tentatively, two structures of the conjugate likely to be formed between o-quinone and methimazole can be suggested; one is analogous to that suggested by Pierpoint (1966) to be formed between o-quinone and cysteine or that suggested by Gupta &Vithayathil (1982) to be formed between dopaquinone and methionine (Scheme la); the other is analogous to that suggested by Sanada et al. (1972) to be formed between o-benzoquinone and cysteine (Scheme lb). These alternatives could best be tested by using the method of Pomerantz (1964) to assay for tyrosinase activity. The data in Fig. 8 tyrosinase, when assayed spectrophotometrically or by radioassay, showed that 5 mM-methimazole caused 80% inhibition when assayed spectrophotometrically and only 60% inhibition when assayed by the release of 3HHO from L-[3,5-H3]tyrosine. Methimazole is not only a copper chelator but is also a powerful OH' scavenger (Cohen et al., 1976) , and one can be tempted to think that the inhibition exerted by methimazole on the o-dihydroxyphenolase activity of mushroom tyrosinase could be due, in part, to this property ofmethimazole. However, it is very unlikely that the inhibition of mushroom tyrosinase by methimazole is due to the latter's ability to scavenge OH', since it was reported that OH radicals were not detected during the enzyme reaction (Hamilton, 1974; Tomita et al., 1980) . Hamilton (1974) did not detect a free radical intermediate in the course of tyrosinase activity, and Tomita et al. (1980) concluded also that OH radicals were not detected in the course of mouse melanoma tyrosinase action on either tyrosine or on DL-dopa.
The results presented in the present paper suggest that methimazole inhibits mushroom tyrosinase activity in two ways: (i) by conjugating with o-quinones to form o-dihydroxyphenol-methimazole conjugate, which has no absorption in the visible range and probably cannot be converted to pigmented products; and (ii) by chelating Cu2+ at the active site of the enzyme.
